REQUEST A DEMO
Total
USD $0.00
Search more companies

Excelsior Biopharma Inc. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Excelsior Biopharma Inc. Profile Updated: May 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Excelsior Biopharma Inc.specializes in medical pharmacy. The company's main business items: prescription drugs, general health products, medical beauty products, etc. Excelsior Biopharma was established in 1988 and located in Taipei City.

Headquarters
5F, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist
Taipei City; Taipei City;

Contact Details: Purchase the Excelsior Biopharma Inc. report to view the information.

Website: http://www.excelsiorgroup.com.tw

Basic Information
Total Employees:
Purchase the Excelsior Biopharma Inc. report to view the information.
Outstanding Shares:
Purchase the Excelsior Biopharma Inc. report to view the information.
Financial Auditors:
Purchase the Excelsior Biopharma Inc. report to view the information.
Incorporation Date:
July 21, 1988
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
21.23%
Purchase this report to view the information.
13.86%
Purchase this report to view the information.
1.08%
Purchase this report to view the information.
0.52%
Purchase this report to view the information.
0.46%
Subsidiaries
科進製藥科技股份有限公司
100%
Company Performance
Financial values in the chart are available after Excelsior Biopharma Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
7.22%
Total operating revenue
7.32%
Operating profit (EBIT)
15.09%
EBITDA
72.35%
Net Profit (Loss) for the Period
9.08%
Total assets
1.53%
Total equity
-8.49%
Operating Profit Margin (ROS)
3.05%
Net Profit Margin
2.43%
Return on Equity (ROE)
0.03%
Quick Ratio
0.17%
Cash Ratio
0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?